Show Summary Details
Page of

Substance Abuse and Comorbidity with Anxiety 

Substance Abuse and Comorbidity with Anxiety
Chapter:
Substance Abuse and Comorbidity with Anxiety
Author(s):

Jenna L. McCauley

, Sudie E. Back

, and Kathleen T. Brady

DOI:
10.1093/med/9780199395125.003.0020
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 15 August 2020

Anxiety symptoms and disorders (AD) often co-occur with substance use disorders (SUD), resulting in variable and multifaceted symptom interactions. AD may serve as a risk factor for development of SUD and may modify the presentation and treatment outcomes for SUD. Conversely, SUD may modify the presentation and treatment outcomes of AD. The first half of this chapter reviews general prevalence estimates of comorbid AD/SUD, discusses etiological theories that have garnered empirical support, and provides an overview of general considerations when approaching the assessment, diagnosis, and treatment of comorbid AD/SUD. The second half of this chapter reviews prevalence estimates, as well as diagnostic and treatment considerations pertinent to specific substance use disorders and specific anxiety disorders.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.